Efficacy and Safety of Mepolizumab in Hypereosinophilic Syndrome: A Phase Ill, Randomized, Placebo-Controlled Trial

被引：0
|
作者：
Steinfeld, J. [1 ]
Rofousse, F. [2 ]
Kahn, J. [3 ]
Gleich, G. [4 ]
Rothenberg, M. [5 ]
Wardlaw, A. [6 ]
Kirby, S. Yun [7 ]
Gilson, M. [8 ]
Bentley, J. [8 ]
Bradford, E. S. [7 ]
Yancey, S. [7 ]
机构：
[1] GlaxoSmithKline, Collegeville, PA USA
[2] Univ Libre Bruxelles, Brussels, Belgium
[3] Univ Versailles St Quentin En Yvelines, Boulogne, France
[4] Univ Utah, Salt Lake City, UT USA
[5] Univ Cincinnati, Cincinnati, OH USA
[6] Univ Leicester, Leicester, Leics, England
[7] GlaxoSmithKline, Res Triangle Pk, NC USA
[8] GlaxoSmithKline, Uxbridge, Middx, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4212
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
    Roufosse, Florence
    Kahn, Jean-Emmanuel
    Rothenberg, Marc E.
    Wardlaw, Andrew J.
    Klion, Amy D.
    Kirby, Suyong Yun
    Gilson, Martyn J.
    Bentley, Jane H.
    Bradford, Eric S.
    Yancey, Steven W.
    Steinfeld, Jonathan
    Gleich, Gerald J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (06) : 1397 - 1405
  • [2] Efficacy ans safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial
    Steinfeld, J.
    Roufosse, F.
    Kahn, J. E.
    Gleich, G. J.
    Rothenberg, M. E.
    Wardlaw, A. J.
    Kirby, S. Y.
    Gilson, M.
    Bentley, J. H.
    Bradford, E. S.
    Yancey, S. W.
    [J]. PNEUMOLOGIE, 2021, 75 : S46 - S47
  • [3] Efficacy and Safety of Pregabalin in the Treatment of Alcohol Withdrawal Syndrome: A Randomized Placebo-Controlled Trial
    Foerg, Anna
    Hein, Jakob
    Volkmar, Katharina
    Winter, Martin
    Richter, Christoph
    Heinz, Andreas
    Mueller, Christian A.
    [J]. ALCOHOL AND ALCOHOLISM, 2012, 47 (02): : 149 - 155
  • [4] Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial
    Kimball, Alexa B.
    Prens, Errol P.
    Passeron, Thierry
    Maverakis, Emanual
    Turchin, Irina
    Beeck, Stefan
    Drogaris, Leonidas
    Geng, Ziqian
    Zhan, Tianyu
    Messina, Izabella
    Bechara, Falk G.
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (05) : 1099 - 1111
  • [5] Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis
    Chmiel, James F.
    Flume, Patrick
    Downey, Damian G.
    Dozor, Allen J.
    Colombo, Carla
    Mazurek, Henryk
    Sapiejka, Ewa
    Rachel, Marta
    Constantine, Scott
    Conley, Brian
    Dgetluck, Nancy
    Dinh, Quinn
    White, Barbara
    Elborn, J. Stuart
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 78 - 85
  • [6] Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial
    Biglan, Kevin
    Munsie, Leanne
    Svensson, Kjell A.
    Ardayfio, Paul
    Pugh, Melissa
    Sims, John
    Brys, Miroslaw
    [J]. MOVEMENT DISORDERS, 2022, 37 (03) : 513 - 524
  • [7] Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis
    Spiera, Robert
    Hummers, Laura
    Chung, Lorinda
    Frech, Tracy M.
    Domsic, Robyn
    Hsu, Vivien
    Furst, Daniel E.
    Gordon, Jessica
    Mayes, Maureen
    Simms, Robert
    Lafyatis, Robert
    Martyanov, Viktor
    Wood, Tammara
    Whitfield, Michael L.
    Constantine, Scott
    Lee, Elizabeth
    Dgetluck, Nancy
    White, Barbara
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (08) : 1350 - 1360
  • [8] A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
    Lewiecki, E. Michael
    Blicharski, Tomasz
    Goemaere, Stefan
    Lippuner, Kurt
    Meisner, Paul D.
    Miller, Paul D.
    Miyauchi, Akimitsu
    Maddox, Judy
    Chen, Li
    Horlait, Stephane
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (09): : 3183 - 3193
  • [9] Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial
    Alexa B. Kimball
    Errol P. Prens
    Thierry Passeron
    Emanual Maverakis
    Irina Turchin
    Stefan Beeck
    Leonidas Drogaris
    Ziqian Geng
    Tianyu Zhan
    Izabella Messina
    Falk G. Bechara
    [J]. Dermatology and Therapy, 2023, 13 : 1099 - 1111
  • [10] Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
    Wechsler, M. E.
    Akuthota, P.
    Jayne, D.
    Khoury, P.
    Klion, A.
    Langford, C.
    Merkel, P. A.
    Moosig, F.
    Specks, U.
    Cid, M. C.
    Luqmani, R.
    Brown, J.
    Mallett, S.
    Philipson, R.
    Yancey, S.
    Steinfeld, J.
    Weller, P. F.
    Gleich, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345